News

Published on 31 Oct 2024 on Investing.com

Earnings call: Bio-Rad reports solid Q3 2024 growth, net income surges By...


Article preview image

The company's net income saw a significant surge to $653 million, largely due to a substantial gain...

NYSE.BIO-B price evolution
NYSE.BIO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Earnings call: Bio-Rad reports solid Q3 2024 growth, net income surges By...

The company's net income saw a significant surge to $653 million, largely due to a substantial ga...

Investing.com 31 Oct 2024

Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical...

Net Sales: $650 million, a 2.8% increase from Q3 2023. Life Science Group Sales: $261 million,...

GuruFocus.com · via Yahoo Finance 31 Oct 2024

Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and...

We recently compiled a list of the 10 Best Organ Transplant and Diagnosis Stocks To Buy Now. In t...

Insider Monkey · via Yahoo Finance 19 Aug 2024

Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its...

The first-quarter results for Bio-Rad Laboratories, Inc. (NYSE:BIO) were released last week, maki...

Simply Wall St. via Yahoo Finance 10 May 2024

Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down

Bio-Rad Laboratories, Inc. BIO posted first-quarter 2024 adjusted earnings per share (EPS) of $2....

Zacks via Yahoo Finance 8 May 2024

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Labora...

Insider Monkey via Yahoo Finance 8 May 2024

Bio-Rad Laboratories Inc (BIO) Q1 2024 Earnings: Mixed Results Amid Market Challenges

Revenue: Reported $610.8 million, a decrease of 9.8% year-over-year, falling short of estimates o...

GuruFocus.com via Yahoo Finance 7 May 2024

Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

(NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLM...

WTNH-TV New Haven 3 May 2024

S&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc.

The S&P 500 opened today at 5,028.85. Within 30 minutes of trading, the benchmark index rose by...

USA Today 23 Apr 2024

New Strong Sell Stocks for April 19th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: ATN International, Inc...

Zacks via Yahoo Finance 19 Apr 2024